PCSK9-IN-19 (Compound 1), a PCSK9 inhibitor, is utilized in researching the treatment of high LDL-cholesterol levels and the prevention of coronary artery disease [1].
Molecular Weight:
1647.37
Formula:
C81H105ClFN15O15S2
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted